Gene Gene synonym Ensembl Gene description Chromosome Position Protein class Evidence HPA evidence UniProt evidence MS evidence Antibody Reliability (IH) Reliability (Mouse Brain) Reliability (IF) Subcellular location RNA tissue category RNA TS RNA TS TPM TPM max in non-specific ANK2 LQT4 ENSG00000145362 Ankyrin 2, neuronal 4 112818109-113383740 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008007, CAB015178, HPA035970 Supported Tissue enhanced 0 cerebral cortex: 184.9 kidney: 124.2 BACE1 BACE ENSG00000186318 Beta-site APP-cleaving enzyme 1 11 117285207-117316259 Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB016358 Approved Supported Plasma membrane Expressed in all pancreas: 100.6 BSG CD147, EMMPRIN, OK ENSG00000172270 Basigin (Ok blood group) 19 571277-583493 Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002427, HPA036048, HPA074870 Supported Approved Vesicles Expressed in all heart muscle: 585.9 BSND BART, DFNB73 ENSG00000162399 Barttin CLCNK-type chloride channel accessory beta subunit 1 54998933-55010883 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA053836 Supported Tissue enriched 6 kidney: 10.2 salivary gland: 1.5 CACNA2D1 CACNA2, CACNL2A, LINC01112, lncRNA-N3, MHS3 ENSG00000153956 Calcium channel, voltage-dependent, alpha 2/delta subunit 1 7 81946444-82443798 FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA008213, HPA008621 Supported Mixed cerebral cortex: 35.5 CACNA2D2 KIAA0558 ENSG00000007402 Calcium channel, voltage-dependent, alpha 2/delta subunit 2 3 50362799-50504244 FDA approved drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA034771, HPA071829 Approved Approved Vesicles Tissue enriched 6 lung: 73.0 testis: 12.4 CACNA2D3 HSA272268 ENSG00000157445 Calcium channel, voltage-dependent, alpha 2/delta subunit 3 3 54122547-55074557 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA030849, HPA030850 Uncertain Nucleus
Cytosol Tissue enhanced 0 cerebral cortex: 16.3 adrenal gland: 5.4 CACNB2 CACNLB2, MYSB ENSG00000165995 Calcium channel, voltage-dependent, beta 2 subunit 10 18140677-18541869 Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035325, HPA035326 Uncertain Mixed cerebral cortex: 26.4 CACNB3 CACNLB3 ENSG00000167535 Calcium channel, voltage-dependent, beta 3 subunit 12 48813794-48828941 FDA approved drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA059515 Approved Golgi apparatus
Vesicles Mixed endometrium: 39.8 CACNB4 EJM4 ENSG00000182389 Calcium channel, voltage-dependent, beta 4 subunit 2 151832776-152099079 Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA015601 Approved Tissue enhanced 0 cerebral cortex: 34.8 skin: 11.2 CACNG1 CACNLG ENSG00000108878 Calcium channel, voltage-dependent, gamma subunit 1 17 67044590-67056797 FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 25 skeletal muscle: 113.5 esophagus: 4.4 CACNG2 MGC138502, MGC138504, stargazin ENSG00000166862 Calcium channel, voltage-dependent, gamma subunit 2 22 36563921-36703558 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 13 cerebral cortex: 15.4 adrenal gland: 1.2 CACNG3 ENSG00000006116 Calcium channel, voltage-dependent, gamma subunit 3 16 24255553-24362801 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA059010 Approved Tissue enriched 28 cerebral cortex: 42.6 adrenal gland: 1.5 CACNG4 MGC11138, MGC24983 ENSG00000075461 Calcium channel, voltage-dependent, gamma subunit 4 17 66964910-67033398 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA005803, HPA065370 Approved Approved Cytosol Tissue enhanced 0 cerebral cortex: 48.7;prostate: 18.8 lung: 9.3 CACNG6 ENSG00000130433 Calcium channel, voltage-dependent, gamma subunit 6 19 53992288-54012669 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA056615 Approved Nucleoli fibrillar center
Cytosol Group enriched 11 fallopian tube: 17.8;skeletal muscle: 33.9 lung: 2.3 CACNG7 ENSG00000105605 Calcium channel, voltage-dependent, gamma subunit 7 19 53909335-53943941 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level Tissue enriched 101 cerebral cortex: 63.9 adrenal gland: 0.6 CACNG8 ENSG00000142408 Calcium channel, voltage-dependent, gamma subunit 8 19 53963040-53990215 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at transcript level Evidence at protein level HPA041351 Supported Tissue enriched 32 cerebral cortex: 23.8 testis: 0.7 CAV1 CAV ENSG00000105974 Caveolin 1, caveolae protein, 22kDa 7 116524785-116561184 Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB003791, HPA049326 Supported Supported Golgi apparatus Tissue enhanced 0 lung: 860.5 adipose tissue: 638.7 CD151 PETA-3, RAPH, SFA-1, TSPAN24 ENSG00000177697 CD151 molecule (Raph blood group) 11 832843-839831 Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002428, HPA011906 Supported Expressed in all smooth muscle: 356.5 CD81 TAPA-1, TAPA1, TSPAN28 ENSG00000110651 CD81 molecule 11 2376177-2397419 CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002507, HPA007234 Supported Supported Plasma membrane Expressed in all seminal vesicle: 2246.2 CD9 BA2, MIC3, MRP-1, P24, TSPAN29 ENSG00000010278 CD9 molecule 12 6199715-6238271 Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB002490 Supported Supported Plasma membrane Expressed in all esophagus: 1009.8 CLDND1 C3orf4 ENSG00000080822 Claudin domain containing 1 3 98497912-98523066 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029841 Approved Approved Nucleus
Nucleoli
Cytosol Expressed in all cerebral cortex: 400.9 CNIH1 CNIH, CNIL, TGAM77 ENSG00000100528 Cornichon family AMPA receptor auxiliary protein 1 14 54423560-54441431 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA002544 Approved Approved Vesicles Expressed in all liver: 118.5 CNTN2 AXT, TAG-1, TAX, TAX1 ENSG00000184144 Contactin 2 (axonal) 1 205043197-205078499 Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA001397, HPA012497 Approved Tissue enriched 12 cerebral cortex: 79.8 testis: 6.9 DLG4 PSD-95, PSD95, SAP-90, SAP90 ENSG00000132535 Discs, large homolog 4 (Drosophila) 17 7189890-7219702 Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001999, CAB002000, HPA010122 Supported Approved Vesicles Tissue enriched 6 cerebral cortex: 179.1 endometrium: 28.9 DMD BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85 ENSG00000198947 Dystrophin X 31097677-33339441 Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB000119, HPA002725, HPA023885 Supported Mixed seminal vesicle: 54.1 DPP6 DPPX ENSG00000130226 Dipeptidyl-peptidase 6 7 153887097-154894285 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA050509 Supported Supported Tissue enhanced 0 cerebral cortex: 51.2;endometrium: 27.4 smooth muscle: 15.2 EMB MGC71745 ENSG00000170571 Embigin 5 50396192-50443248 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Mixed bone marrow: 94.9 EPB41 4.1R, EL1 ENSG00000159023 Erythrocyte membrane protein band 4.1 1 28887091-29120046 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA028076, HPA028412, HPA028414 Supported Supported Plasma membrane
Cell Junctions
Cytosol Expressed in all lymph node: 51.3 ERLEC1 C2orf30, CL25084, ERLECTIN, XTP3-B, XTP3TPB ENSG00000068912 Endoplasmic reticulum lectin 1 2 53787044-53818819 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA031501, HPA031502, HPA031503 Approved Expressed in all thyroid gland: 121.4 FABP5 E-FABP, KFABP, PA-FABP ENSG00000164687 Fatty acid binding protein 5 (psoriasis-associated) 8 81280363-81284777 Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB017831, CAB040577, HPA051895 Supported Supported Plasma membrane
Cytosol Expressed in all esophagus: 1671.2 GSG1 MGC3146 ENSG00000111305 Germ cell associated 1 12 13083560-13103683 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 364 testis: 571.3 duodenum: 1.5 GSG1L KTSR5831, MGC18079, PRO19651 ENSG00000169181 GSG1-like 16 27787535-28063509 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA014479 Approved Tissue enhanced 0 cerebral cortex: 11.7;heart muscle: 8.8 fallopian tube: 2.7 HAMP HEPC, HFE2B, LEAP-1, LEAP1 ENSG00000105697 Hepcidin antimicrobial peptide 19 35280716-35285143 Disease related genes, Potential drug targets, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Tissue enriched 7 liver: 257.0 heart muscle: 38.7 HEPACAM FLJ25530, GLIALCAM, hepaCAM ENSG00000165478 Hepatic and glial cell adhesion molecule 11 124919193-124936412 Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA017613, CAB025486 Supported Approved Vesicles Tissue enriched 6 cerebral cortex: 80.9 adipose tissue: 14.4 IFITM1 9-27, CD225, IFI17 ENSG00000185885 Interferon induced transmembrane protein 1 11 313506-315272 CD markers, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA004810, CAB017615 Supported Supported Cytosol Expressed in all epididymis: 904.7 IFITM2 1-8D ENSG00000185201 Interferon induced transmembrane protein 2 11 307631-315272 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004337 Uncertain Expressed in all appendix: 722.4 IFITM3 1-8U ENSG00000142089 Interferon induced transmembrane protein 3 11 319669-327537 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA004337 Uncertain Expressed in all fallopian tube: 1027.4 ITGA1 CD49a, VLA1 ENSG00000213949 Integrin, alpha 1 5 52787896-52959210 Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA042555 Uncertain Approved Endoplasmic reticulum Mixed spleen: 78.9 ITGA6 CD49f ENSG00000091409 Integrin, alpha 6 2 172427354-172506282 Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB009009, HPA012696, HPA027582 Supported Expressed in all placenta: 114.3 IZUMO1 IZUMO, MGC34799, OBF ENSG00000182264 Izumo sperm-egg fusion 1 19 48740852-48746909 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038104 Supported Tissue enriched 22 testis: 19.2 lung: 0.8 IZUMO2 C19orf41, MGC33947, SCRL ENSG00000161652 IZUMO family member 2 19 50152548-50163195 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA042143 Uncertain Tissue enriched 255 testis: 55.9 thyroid gland: 0.2 IZUMO3 bA20A20.1, C9orf134 ENSG00000205442 IZUMO family member 3 9 24542952-24545946 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level No evidence Tissue enriched 238 testis: 23.8 adipose tissue: 0.0 IZUMO4 C19orf36 ENSG00000099840 IZUMO family member 4 19 2096429-2099593 Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA045099, HPA048496 Approved Uncertain Nucleoplasm
Vesicles Tissue enriched 52 testis: 341.4 ovary: 6.5 KCNAB1 AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3 ENSG00000169282 Potassium channel, voltage gated subfamily A regulatory beta subunit 1 3 156037701-156539138 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA044550 Approved Tissue enhanced 0 thyroid gland: 48.3 prostate: 37.6 KCNMB1 hslo-beta ENSG00000145936 Potassium channel subfamily M regulatory beta subunit 1 5 170374671-170389677 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enhanced 0 seminal vesicle: 63.6;smooth muscle: 69.0 endometrium: 41.9 KCNMB2 ENSG00000197584 Potassium channel subfamily M regulatory beta subunit 2 3 178272932-178844429 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB022649 Uncertain Tissue enhanced 0 epididymis: 41.5;fallopian tube: 22.1;ovary: 19.0 adrenal gland: 7.6 KCNMB3 KCNMB2, KCNMBL ENSG00000171121 Potassium channel subfamily M regulatory beta subunit 3 3 179236691-179267002 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA015665, HPA019185 Approved Approved Nucleus
Mitochondria Mixed placenta: 5.9 KL ENSG00000133116 Klotho 13 33016433-33066145 Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Group enriched 5 kidney: 135.6;parathyroid gland: 340.1 placenta: 43.7 KLB ENSG00000134962 Klotho beta 4 39406853-39451536 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA021136 Uncertain Tissue enhanced 0 adipose tissue: 20.6;liver: 9.1 testis: 5.1 LRRC55 FLJ45686 ENSG00000183908 Leucine rich repeat containing 55 11 57181747-57191717 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA014053 Uncertain Tissue enhanced 0 cerebral cortex: 6.6 lymph node: 2.4 LYNX1 SLURP2 ENSG00000180155 Ly6/neurotoxin 1 8 142764334-142778224 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA023711 Approved Tissue enhanced 0 esophagus: 346.7 skin: 140.2 LYPD6B CT116, LYPD7 ENSG00000150556 LY6/PLAUR domain containing 6B 2 149038107-149215262 Predicted secreted proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA049239 Uncertain Tissue enhanced 0 gallbladder: 58.8;skin: 56.6 testis: 42.1 MICU1 CALC, CBARA1, EFHA3, FLJ12684 ENSG00000107745 Mitochondrial calcium uptake 1 10 72367327-72626191 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA037479, HPA037480 Uncertain Supported Mitochondria Expressed in all kidney: 107.0 MICU2 EFHA1 ENSG00000165487 Mitochondrial calcium uptake 2 13 21492691-21604214 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA045511, HPA058790 Approved Approved Nucleus
Mitochondria Expressed in all kidney: 77.9 NEDD4 KIAA0093, MGC176705, NEDD4-1, RPF1 ENSG00000069869 Neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase 15 55826922-55993746 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level CAB001991, HPA039883, CAB072833 Approved Approved Cytosol Mixed placenta: 22.3 NETO1 BCTL1, BTCL1 ENSG00000166342 Neuropilin (NRP) and tolloid (TLL)-like 1 18 72742314-72868146 Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA064630 Approved Golgi apparatus Tissue enriched 15 cerebral cortex: 64.1 spleen: 4.1 NETO2 FLJ10430, NEOT2 ENSG00000171208 Neuropilin (NRP) and tolloid (TLL)-like 2 16 47077703-47143997 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA013180 Uncertain Approved Golgi apparatus Tissue enhanced 0 spleen: 32.0 cerebral cortex: 21.0 OS9 ERLEC2, OS-9 ENSG00000135506 Osteosarcoma amplified 9, endoplasmic reticulum lectin 12 57693955-57721557 Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB011518, HPA013694 Supported Expressed in all parathyroid gland: 290.9 PIRT ENSG00000233670 Phosphoinositide-interacting regulator of transient receptor potential channels 17 10822475-10838445 Predicted membrane proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA042337 Uncertain Uncertain Plasma membrane
Cytosol Tissue enhanced 0 adrenal gland: 3.1;cerebral cortex: 2.7;rectum: 2.7 colon: 2.1 PRPH2 CACD2, rd2, RDS, RP7, TSPAN22 ENSG00000112619 Peripherin 2 (retinal degeneration, slow) 6 42696600-42722574 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029458 Supported Mixed parathyroid gland: 8.5 RBP2 CRABP-II, CRBP2, CRBPII, RBPC2 ENSG00000114113 Retinol binding protein 2, cellular 3 139452884-139480747 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA035866 Supported Approved Golgi apparatus Group enriched 207 duodenum: 2824.3;small intestine: 2085.7 lung: 11.8 SCN2B ENSG00000149575 Sodium channel, voltage gated, type II beta subunit 11 118161951-118176673 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level Tissue enriched 5 cerebral cortex: 34.8 heart muscle: 6.7 SCN4B LQT10 ENSG00000177098 Sodium channel, voltage gated, type IV beta subunit 11 118133377-118152888 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA017293 Approved Tissue enhanced 0 adipose tissue: 25.0 thyroid gland: 17.0 SIGMAR1 OPRS1, SR-BP1 ENSG00000147955 Sigma non-opioid intracellular receptor 1 9 34634722-34637809 Disease related genes, FDA approved drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB013470, HPA018002, HPA024071 Approved Expressed in all liver: 67.8 SLC3A1 ATR1, CSNU1, D2H, NBAT, RBAT ENSG00000138079 Solute carrier family 3 (amino acid transporter heavy chain), member 1 2 44275458-44321494 Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA038360 Supported Tissue enhanced 0 kidney: 649.8 small intestine: 151.9 SLC3A2 4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE ENSG00000168003 Solute carrier family 3 (amino acid transporter heavy chain), member 2 11 62856102-62888875 Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB010455, HPA017980 Supported Supported Nucleus
Plasma membrane
Cytosol Expressed in all parathyroid gland: 424.3 SLC9A3R1 EBP50, NHERF ENSG00000109062 Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 17 74748652-74769353 Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level CAB001962, HPA009672, HPA027247 Supported Approved Vesicles
Plasma membrane
Microtubule organizing center Expressed in all small intestine: 308.5 SLC9A3R2 E3KARP, NHERF-2, SIP-1, TKA-1 ENSG00000065054 Solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 2 16 2025356-2039026 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA001672 Approved Supported Plasma membrane Mixed lung: 161.9 SMDT1 C22orf32, DDDD, dJ186O1.1, EMRE ENSG00000183172 Single-pass membrane protein with aspartate-rich tail 1 22 42079691-42084284 Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA032117, HPA060340 Uncertain Supported Nucleus
Mitochondria Expressed in all thyroid gland: 7.8 STAC STAC1 ENSG00000144681 SH3 and cysteine rich domain 3 36380344-36548007 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level HPA035143 Uncertain Uncertain Nucleoplasm
Plasma membrane Tissue enhanced 0 parathyroid gland: 23.0;prostate: 20.0 lung: 15.8 STOM BND7, EPB7, EPB72 ENSG00000148175 Stomatin 9 121338988-121370304 Plasma proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA010961, HPA011419 Approved Validated Cytosol Expressed in all adipose tissue: 461.2 TMEM110 MGC52022 ENSG00000213533 Transmembrane protein 110 3 52836219-52897596 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA051855 Uncertain Approved Cytosol Expressed in all fallopian tube: 20.8 TMEM139 FLJ90586 ENSG00000178826 Transmembrane protein 139 7 143279957-143288048 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level HPA036982, HPA036983 Approved Approved Plasma membrane
Focal adhesion sites Tissue enhanced 0 duodenum: 34.9;kidney: 34.4 small intestine: 21.2 TMEM178A MGC33926, TMEM178 ENSG00000152154 Transmembrane protein 178A 2 39664982-39717963 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at transcript level Evidence at transcript level Evidence at transcript level HPA052128, HPA058560 Uncertain Approved Nucleus
Vesicles Tissue enhanced 0 cerebral cortex: 55.6 kidney: 19.1 TMEM30A C6orf67, CDC50A, FLJ10856 ENSG00000112697 Transmembrane protein 30A 6 75252924-75284968 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA014561 Approved Supported Mitochondria Expressed in all cerebral cortex: 167.9 TMEM30B CDC50B ENSG00000182107 Transmembrane protein 30B 14 61277370-61281840 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA043162 Uncertain Mixed parathyroid gland: 80.6 TMEM57 FLJ10747 ENSG00000204178 Transmembrane protein 57 1 25430858-25500209 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA019680 Approved Cytosol Expressed in all testis: 36.0 TMUB1 C7orf21, SB144 ENSG00000164897 Transmembrane and ubiquitin-like domain containing 1 7 151081080-151083546 Predicted membrane proteins, Predicted secreted proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA029429 Approved Supported Nucleoplasm
Cytosol Expressed in all small intestine: 53.3 TSPAN33 MGC50844, Penumbra ENSG00000158457 Tetraspanin 33 7 129144892-129169697 Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at transcript level Evidence at protein level HPA020357 Approved Approved Microtubules Expressed in all kidney: 126.4 TSPAN7 A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2 ENSG00000156298 Tetraspanin 7 X 38561370-38688920 CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA003140, CAB062566, CAB068245 Supported Tissue enriched 6 cerebral cortex: 576.3 adrenal gland: 99.7 UBQLN4 A1U, C1orf6, UBIN ENSG00000160803 Ubiquilin 4 1 156035301-156053794 Predicted intracellular proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA061797 Approved Supported Nucleus Expressed in all cerebral cortex: 41.2 WFS1 DFNA14, DFNA38, DFNA6, DIDMOAD, WFS ENSG00000109501 Wolfram syndrome 1 (wolframin) 4 6269849-6303265 Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters Evidence at protein level Evidence at transcript level Evidence at protein level Evidence at protein level HPA029128 Approved Mixed ovary: 61.4 WLS C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP, wls ENSG00000116729 Wntless Wnt ligand secretion mediator 1 68098473-68233120 Predicted intracellular proteins, Predicted membrane proteins, Transporters Evidence at protein level Evidence at protein level Evidence at protein level Evidence at protein level HPA069520 Approved Supported Endoplasmic reticulum Expressed in all epididymis: 160.7